A CRISPR activation screen identifies ABCC1 as a potential therapeutic target in actinomycin D-resistant high-risk pediatric rhabdomyosarcoma
- Weitere Titel
-
Identifikation von ABCC1 als potenziellen Angriffspunkt in Actinomycin D-resistenten, pädiatrischen Hochrisiko-Rhabdomyosarkomen: ein CRISPR-Aktivationsscreen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Medizinische Fakultät Charité - Universitätsmedizin Berlin, Dissertation, 2023
- Schlagwort
-
Krebs
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Medizinische Fakultät Charité - Universitätsmedizin Berlin
- (wann)
-
2023
- Urheber
-
von Stebut, Jennifer Shu-Han
- DOI
-
10.17169/refubium-40560
- URN
-
urn:nbn:de:kobv:188-refubium-40839-8
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- von Stebut, Jennifer Shu-Han
- Medizinische Fakultät Charité - Universitätsmedizin Berlin
Entstanden
- 2023
Ähnliche Objekte (12)
CRISPR/Cas9 library screening identifies PIP4K2C as regulator of PVR
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Complementary CRISPR screen identifies novel mechanisms of cytotoxic T cell inhibition by tumor cells
CRISPR/Cas9-mediated generation and characterization of glucocorticoid-resistant virus-specific T cells
Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms
Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast Cancer
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
A Multiplex CRISPR‐Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes that Contribute to Gemcitabine Resistance in Pancreatic Cancer
Wechselwirkungen von Proteinen mit Actinomycin C
CRISPR/Cas9 library screening identifies PIP4K2C as regulator of PVR
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Complementary CRISPR screen identifies novel mechanisms of cytotoxic T cell inhibition by tumor cells
CRISPR/Cas9-mediated generation and characterization of glucocorticoid-resistant virus-specific T cells
Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms
Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast Cancer
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
A Multiplex CRISPR‐Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes that Contribute to Gemcitabine Resistance in Pancreatic Cancer
Wechselwirkungen von Proteinen mit Actinomycin C
CRISPR/Cas9 library screening identifies PIP4K2C as regulator of PVR
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Complementary CRISPR screen identifies novel mechanisms of cytotoxic T cell inhibition by tumor cells
CRISPR/Cas9-mediated generation and characterization of glucocorticoid-resistant virus-specific T cells
Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms
Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast Cancer
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
A Multiplex CRISPR‐Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes that Contribute to Gemcitabine Resistance in Pancreatic Cancer